| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K13185470 |
| PharmacoGx | BRD-K13185470 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLAGL2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | RNF212B | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | L3HYPDH | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | NAIF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | TAF4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | TNFSF12 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | SLC10A7 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | FBXO43 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | USP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | HAPLN3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
